The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome

Steven M Claypool, Pinmanee Boontheung, J. Michael McCaffery, Joseph A. Loo, Carla M. Koehler

Research output: Contribution to journalArticle

Abstract

Mutations in the mitochondrial cardiolipin (CL) transacylase, tafazzin (Taz1p), result in the X-linked cardioskeletal myopathy, Barth syndrome (BTHS). The mitochondria of BTHS patients exhibit variable respiratory defects and abnormal cristae ultrastructure. The biochemical basis for these observations is unknown. In the absence of its target phospholipid, CL, a very large Taz1p complex is missing, whereas several discrete smaller complexes are still observed. None of the identified Taz1p complexes represents Taz1p homodimers. Instead, yeast Taz1p physically assembles in several protein complexes of distinct size and composition. The ATP synthase and AAC2, both required for oxidative phosphorylation, are identified in separate stable Taz1p complexes. In the absence of CL, each interaction is still detected albeit in reduced abundance compared with when CL is present. Taz1p is not necessary for the normal expression of AAC2 or ATP synthase subunits or assembly of their respective complexes. In contrast, the largest Taz1p complex requires assembled ATP synthase and CL. Mitochondria in Δtaz1 yeast, similar to ATP synthase oligomer mutants, exhibit altered cristae morphology even though ATP synthase oligomer formation is unaffected. Thus, the Taz1p interactome defined here provides novel insight into the variable respiratory defects and morphological abnormalities observed in mitochondria of BTHS patients.

Original languageEnglish (US)
Pages (from-to)5143-5155
Number of pages13
JournalMolecular Biology of the Cell
Volume19
Issue number12
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Barth Syndrome
Cardiolipins
Adenosine Triphosphate
Mitochondria
Yeasts
Oxidative Phosphorylation
Muscular Diseases
Phospholipids
Mutation

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. / Claypool, Steven M; Boontheung, Pinmanee; McCaffery, J. Michael; Loo, Joseph A.; Koehler, Carla M.

In: Molecular Biology of the Cell, Vol. 19, No. 12, 12.2008, p. 5143-5155.

Research output: Contribution to journalArticle

Claypool, Steven M ; Boontheung, Pinmanee ; McCaffery, J. Michael ; Loo, Joseph A. ; Koehler, Carla M. / The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. In: Molecular Biology of the Cell. 2008 ; Vol. 19, No. 12. pp. 5143-5155.
@article{f9bf1e5bb12943e38e26e4892fa12511,
title = "The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome",
abstract = "Mutations in the mitochondrial cardiolipin (CL) transacylase, tafazzin (Taz1p), result in the X-linked cardioskeletal myopathy, Barth syndrome (BTHS). The mitochondria of BTHS patients exhibit variable respiratory defects and abnormal cristae ultrastructure. The biochemical basis for these observations is unknown. In the absence of its target phospholipid, CL, a very large Taz1p complex is missing, whereas several discrete smaller complexes are still observed. None of the identified Taz1p complexes represents Taz1p homodimers. Instead, yeast Taz1p physically assembles in several protein complexes of distinct size and composition. The ATP synthase and AAC2, both required for oxidative phosphorylation, are identified in separate stable Taz1p complexes. In the absence of CL, each interaction is still detected albeit in reduced abundance compared with when CL is present. Taz1p is not necessary for the normal expression of AAC2 or ATP synthase subunits or assembly of their respective complexes. In contrast, the largest Taz1p complex requires assembled ATP synthase and CL. Mitochondria in Δtaz1 yeast, similar to ATP synthase oligomer mutants, exhibit altered cristae morphology even though ATP synthase oligomer formation is unaffected. Thus, the Taz1p interactome defined here provides novel insight into the variable respiratory defects and morphological abnormalities observed in mitochondria of BTHS patients.",
author = "Claypool, {Steven M} and Pinmanee Boontheung and McCaffery, {J. Michael} and Loo, {Joseph A.} and Koehler, {Carla M.}",
year = "2008",
month = "12",
doi = "10.1091/mbc.E08-09-0896",
language = "English (US)",
volume = "19",
pages = "5143--5155",
journal = "Molecular Biology of the Cell",
issn = "1059-1524",
publisher = "American Society for Cell Biology",
number = "12",

}

TY - JOUR

T1 - The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome

AU - Claypool, Steven M

AU - Boontheung, Pinmanee

AU - McCaffery, J. Michael

AU - Loo, Joseph A.

AU - Koehler, Carla M.

PY - 2008/12

Y1 - 2008/12

N2 - Mutations in the mitochondrial cardiolipin (CL) transacylase, tafazzin (Taz1p), result in the X-linked cardioskeletal myopathy, Barth syndrome (BTHS). The mitochondria of BTHS patients exhibit variable respiratory defects and abnormal cristae ultrastructure. The biochemical basis for these observations is unknown. In the absence of its target phospholipid, CL, a very large Taz1p complex is missing, whereas several discrete smaller complexes are still observed. None of the identified Taz1p complexes represents Taz1p homodimers. Instead, yeast Taz1p physically assembles in several protein complexes of distinct size and composition. The ATP synthase and AAC2, both required for oxidative phosphorylation, are identified in separate stable Taz1p complexes. In the absence of CL, each interaction is still detected albeit in reduced abundance compared with when CL is present. Taz1p is not necessary for the normal expression of AAC2 or ATP synthase subunits or assembly of their respective complexes. In contrast, the largest Taz1p complex requires assembled ATP synthase and CL. Mitochondria in Δtaz1 yeast, similar to ATP synthase oligomer mutants, exhibit altered cristae morphology even though ATP synthase oligomer formation is unaffected. Thus, the Taz1p interactome defined here provides novel insight into the variable respiratory defects and morphological abnormalities observed in mitochondria of BTHS patients.

AB - Mutations in the mitochondrial cardiolipin (CL) transacylase, tafazzin (Taz1p), result in the X-linked cardioskeletal myopathy, Barth syndrome (BTHS). The mitochondria of BTHS patients exhibit variable respiratory defects and abnormal cristae ultrastructure. The biochemical basis for these observations is unknown. In the absence of its target phospholipid, CL, a very large Taz1p complex is missing, whereas several discrete smaller complexes are still observed. None of the identified Taz1p complexes represents Taz1p homodimers. Instead, yeast Taz1p physically assembles in several protein complexes of distinct size and composition. The ATP synthase and AAC2, both required for oxidative phosphorylation, are identified in separate stable Taz1p complexes. In the absence of CL, each interaction is still detected albeit in reduced abundance compared with when CL is present. Taz1p is not necessary for the normal expression of AAC2 or ATP synthase subunits or assembly of their respective complexes. In contrast, the largest Taz1p complex requires assembled ATP synthase and CL. Mitochondria in Δtaz1 yeast, similar to ATP synthase oligomer mutants, exhibit altered cristae morphology even though ATP synthase oligomer formation is unaffected. Thus, the Taz1p interactome defined here provides novel insight into the variable respiratory defects and morphological abnormalities observed in mitochondria of BTHS patients.

UR - http://www.scopus.com/inward/record.url?scp=59449108212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449108212&partnerID=8YFLogxK

U2 - 10.1091/mbc.E08-09-0896

DO - 10.1091/mbc.E08-09-0896

M3 - Article

C2 - 18799610

AN - SCOPUS:59449108212

VL - 19

SP - 5143

EP - 5155

JO - Molecular Biology of the Cell

JF - Molecular Biology of the Cell

SN - 1059-1524

IS - 12

ER -